Click to Share
 

Drug Design Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By SMi Group
Astra Zeneca, Pfizer, Astex Pharmaceuticals, ZoBio and Chemical Computing Group to discuss identification of lead inhibitors and structural optimisation of protein ligands with therapeutic efficacy at SMi's Advances and Progress in Drug Design 2016
12397929
By SMi Group
14th annual conference on Advances & Progress in Drug Design, 16th and 17th February 2015, Marriott Regents Park Hotel, London UK
12389210
By SMi Group
Advances and Progress in Drug Design, 16th and 17th February, London UK
12377577
By SMi Group Ltd
Advances and Progress in Drug Design, 16th & 17th February 2015, Marriott Regents Park Hotel, London UK
By Ariel Fernandez Consultancy
Protein structural defects are key players in enzyme catalysis
12305393
By Cambridge Healthtech Institute
Organized by Cambridge Healthtech Institute (CHI) to be held prior to the start of the 14th Annual Structure-Based Drug Design conference.
12290698
By Cambridge Healthtech Institute
Listen to this free podcast with Jason Burch, Ph.D., Scientist, Medicinal Chemistry, Genentech
12278845
By SMi Group
John Mathias, Senior Director, Head of Medicinal Chemistry at Pfizer, to chair 13th annual conference on Advances and Progress in Drug Design
12275737
By SMi Group
SMi presents the 11th Controlled Release conference taking place in London on the 12th and 13th of March.
12274543
By SMi Group
Just 3 weeks remain until SMi open their doors to host the industry established conference on Advances and Progress in Drug Design.
12269170
By Cambridge Healthtech Institute
Top scientists from pharma and biotech to deliver new data and case studies for using structure and rational design to accelerate discovery
By SMi Group
Today more than ever regulatory guidance is increasingly focussing on the process robustness and product quality. The pharma world is also changing at an increasingly quickening pace.
By Cambridge Healthtech Institute
Cambridge Healthtech Institute's Strategies for Companion Diagnostics Development Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at the Moscone North Convention Center in San Francisco.
By SMi Group
SMi’s 12th annual conference on Drug Design taking place on the 18th & 19th February 2013 in London will provide attendees with an unparalleled opportunity for debate and problem solving of key challenges currently facing the field.
By Cambridge Healthtech Institute
In silico Lead Finding through Holistic Understanding of Screening Data from Multiple Approaches
By Cambridge Healthtech Institute
Event Focus will be Predicting Biological and Kinetic Profiles from Structure

All Press Releases

By SMi Group
Astra Zeneca, Pfizer, Astex Pharmaceuticals, ZoBio and Chemical Computing Group to discuss identification of lead inhibitors and structural optimisation of protein ligands with therapeutic efficacy at SMi's Advances and Progress in Drug Design 2016
By SMi Group Ltd
In just a few weeks, SMi’s 14th annual conference on Advances and Progress in Drug Design, will open its doors to gather scientific leaders and industry KOLS from the drug design arena.
By SMi Group Ltd
SMi’s 14th annual Advances & Progress in Drug Design conference will take place on the 16th - 17th February 2015 in Marriott Regents Park Hotel, London, UK
12397929
By SMi Group
14th annual conference on Advances & Progress in Drug Design, 16th and 17th February 2015, Marriott Regents Park Hotel, London UK
12389210
By SMi Group
Advances and Progress in Drug Design, 16th and 17th February, London UK
12377577
By SMi Group Ltd
Advances and Progress in Drug Design, 16th & 17th February 2015, Marriott Regents Park Hotel, London UK
By Ariel Fernandez Consultancy
Protein structural defects are key players in enzyme catalysis
12305393
By Cambridge Healthtech Institute
Organized by Cambridge Healthtech Institute (CHI) to be held prior to the start of the 14th Annual Structure-Based Drug Design conference.
12290698
By Cambridge Healthtech Institute
Listen to this free podcast with Jason Burch, Ph.D., Scientist, Medicinal Chemistry, Genentech
12278845
By SMi Group
John Mathias, Senior Director, Head of Medicinal Chemistry at Pfizer, to chair 13th annual conference on Advances and Progress in Drug Design
12275737
By SMi Group
SMi presents the 11th Controlled Release conference taking place in London on the 12th and 13th of March.
12274543
By SMi Group
Just 3 weeks remain until SMi open their doors to host the industry established conference on Advances and Progress in Drug Design.
12269170
By Cambridge Healthtech Institute
Top scientists from pharma and biotech to deliver new data and case studies for using structure and rational design to accelerate discovery
By SMi Group
Today more than ever regulatory guidance is increasingly focussing on the process robustness and product quality. The pharma world is also changing at an increasingly quickening pace.
By Cambridge Healthtech Institute
Featuring Keynote From Aileron Therapeutics’ Tomi Sawyer. Early registration discounts will be offerered until March 22.
By Cambridge Healthtech Institute
Cambridge Healthtech Institute's Strategies for Companion Diagnostics Development Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at the Moscone North Convention Center in San Francisco.
By SMi Group
SMi’s 12th annual conference on Drug Design taking place on the 18th & 19th February 2013 in London will provide attendees with an unparalleled opportunity for debate and problem solving of key challenges currently facing the field.
By Cambridge Healthtech Institute
This conference will be held on June 6-8, 2012 at the Royal Sonesta Hotel Boston in Cambridge, MA. Advance registration discounts end on May 4.
By Cambridge Healthtech Institute
In silico Lead Finding through Holistic Understanding of Screening Data from Multiple Approaches
By Cambridge Healthtech Institute
Dr. Merz will present in the free energy calculation and molecular dynamics simulation session.
By Cambridge Healthtech Institute
Dr. Copeland will present in the druggability and kinetics-based drug design session.
By Cambridge Healthtech Institute
Event Focus will be Predicting Biological and Kinetic Profiles from Structure
By SMi Group
SMi’s Drug Design Conference will aim to address many of the challenging issues faced by the pharmaceutical industry in drug design. Key selected industry experts will provide you with timely and up-to-date information on many areas of drug design.
By GTCbio
J. Carmel Egan, Vice President of Project Management at Eli Lilly and Company, to give a plenary keynote presentation at 7th Modern Drug Discovery and Development Summit (Oct 19-21, 2011 in San Diego, CA)
By GTC Conferences
Yibing Shan, Senior Scientist of Chemistry and Biology at D. E. Shaw Research, to give a presentation at 5th Drug Design and Medicinal Chemistry Conference (Oct 19-21, 2011 in San Diego, CA)
By GTC Conferences
Juswinder Singh, Co-Founder and Chief Scientific Officer at Avila Therapeutics, to give a presentation at 5th Drug Design and Medicinal Chemistry Conference (Oct 19-21, 2011 in San Diego, CA)
By Cambridge Healthtech Institute
CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: New Targets and Drug Modalities
By Cambridge Healthtech Institute
CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: Free Energy Approach to Structure-Based Drug Design
By Cambridge Healthtech Institute
CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: Fragment-Based Drug Design
By Cambridge Healthtech Institute
CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: Protein Flexibility and Druggability

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share